Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-28

FDA Approved: MOXIFLOXACIN — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' MOXIFLOXACIN as a generic moxifloxacin ophthalmic solution; the approval covers its use for bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin (moxifloxacin)

Snippet

ORIG AP for MOXIFLOXACIN (MOXIFLOXACIN)